Uechi M, Asai K, Sato N, Vatner S F
Cardiovascular and Pulmonary Research Institute, Allegheny University of the Health Sciences, Pittsburgh, PA 15212, USA.
Circulation. 1998 Sep 29;98(13):1342-7. doi: 10.1161/01.cir.98.13.1342.
The aim of this study was to determine the mechanism by which the calcium channel promoter BAY y 5959 affects the control of heart rate and baroreflex sensitivity in conscious dogs with pacing-induced heart failure (HF).
We compared responses to BAY y 5959, which increases inotropy and decreases chronotropy, with those to norepinephrine (NE), which coincidentally exerts the same directional effects on inotropy and chronotropy, albeit through different mechanisms, in the presence and absence of ganglionic blockade both in control and in HF. Both BAY y 5959 and NE elicit direct effects on the heart and indirect effects through activation of reflexes, primarily the sinoaortic baroreceptor reflex. BAY y 5959 still reduced heart rate in dogs with arterial baroreceptor denervation, but not after ganglionic blockade. HF induced classic catecholamine desensitization to the inotropic effects of NE and blunted reflex bradycardia. In contrast, inotropic responses to BAY y 5959 were preserved in HF. Surprisingly, the autonomically mediated bradycardia induced by BAY y 5959 was also preserved in HF. Baroreflex sensitivity was assessed in control and in HF by pulse interval-systolic arterial blood pressure (PI/SAP) slopes constructed in response to pharmacological alterations in arterial pressure. HF depressed the PI/SAP slope from 11.5+/-1.3 to 4.8+/-0.9 ms/mm Hg, but during BAY y 5959 infusion in HF, the PI/SAP slope was restored to 24.1+/-5.2 ms/mm Hg. To assess central versus peripheral actions of BAY y 5959, the agent was infused with intra-carotid artery perfusion at a low dose, which acted centrally but did not have an effect peripherally. Under these conditions, it still decreased heart rate and restored baroreflex sensitivity (PI/SAP slope, 12.7+/-2.8 ms/mm Hg).
Thus, the calcium promoter restores arterial baroreflex sensitivity in HF. Based on intra-carotid artery experiments, this occurs through a central nervous system and vagal mechanism.
本研究旨在确定钙通道激动剂BAY y 5959影响起搏诱导的心力衰竭(HF)清醒犬心率控制和压力反射敏感性的机制。
我们比较了在对照和HF状态下,在存在和不存在神经节阻断的情况下,增加心肌收缩力并降低心率的BAY y 5959与去甲肾上腺素(NE)的反应,NE虽然通过不同机制,但对心肌收缩力和心率产生相同方向的影响。BAY y 5959和NE均对心脏产生直接作用,并通过激活反射,主要是窦主动脉压力感受器反射产生间接作用。BAY y 5959在动脉压力感受器去神经支配的犬中仍能降低心率,但在神经节阻断后则不能。HF诱导了对NE正性肌力作用的经典儿茶酚胺脱敏,并减弱了反射性心动过缓。相比之下,HF时对BAY y 5959的正性肌力反应得以保留。令人惊讶的是,BAY y 5959诱导的自主神经介导的心动过缓在HF中也得以保留。通过响应动脉压力药理学改变构建的脉搏间期-收缩期动脉血压(PI/SAP)斜率,在对照和HF中评估压力反射敏感性。HF使PI/SAP斜率从11.5±1.3降至4.8±0.9 ms/mm Hg,但在HF中输注BAY y 5959期间,PI/SAP斜率恢复至24.1±5.2 ms/mm Hg。为了评估BAY y 5959的中枢与外周作用,以低剂量通过颈内动脉灌注该药物,其作用于中枢但对外周无影响。在这些条件下,它仍能降低心率并恢复压力反射敏感性(PI/SAP斜率,12.7±2.8 ms/mm Hg)。
因此,钙通道激动剂可恢复HF中的动脉压力反射敏感性。基于颈内动脉实验,这是通过中枢神经系统和迷走神经机制发生的。